StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.09−0.04 (-0.49%)

Close on Nov 13, 2026Market cap $466.68MP/E –Yield –

Kamada total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Kamada's total debt was $6.03M at Jun 30, 2026. For fiscal 2025 it was $9.92M, down 2.5% from the year before. The highest annual figure on record is $22.67M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.92M-2.5%
FY2024Dec 31, 2024$10.18M-32.1%
FY2023Dec 31, 2023$15.00M-13.9%
FY2022Dec 31, 2022$17.41M-23.2%
FY2021Dec 31, 2021$22.67M+4327.5%
FY2020Dec 31, 2020$512.00K-58.5%
FY2019Dec 31, 2019$1.24M+8.3%
FY2018Dec 31, 2018$1.14M-56.1%
FY2017Dec 31, 2017$2.60M+18.7%
FY2016Dec 31, 2016$2.19M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.03M-38.8%
Q1 FY2026Mar 31, 2026$10.64M-2.3%
Q4 FY2025Dec 31, 2025$9.92M-2.5%
Q3 FY2025Sep 30, 2025$10.59M+11.7%
Q2 FY2025Jun 30, 2025$9.85M-21.9%
Q1 FY2025Mar 31, 2025$10.89M-16.1%
Q4 FY2024Dec 31, 2024$10.18M-32.1%
Q3 FY2024Sep 30, 2024$9.48M-40.7%
Q2 FY2024Jun 30, 2024$12.61M-17.0%
Q1 FY2024Mar 31, 2024$12.98M+191.3%
Q4 FY2023Dec 31, 2023$15.00M-13.9%
Q3 FY2023Sep 30, 2023$15.99M+359688.5%
Q2 FY2023Jun 30, 2023$15.19M+241.3%
Q1 FY2023Mar 31, 2023$4.46M+19.6%
Q4 FY2022Dec 31, 2022$17.41M-23.2%
Q3 FY2022Sep 30, 2022$4.44K-91.5%
Q2 FY2022Jun 30, 2022$4.45M+7193.4%
Q1 FY2022Mar 31, 2022$3.73M+627.5%
Q4 FY2021Dec 31, 2021$22.67M+6940.1%
Q3 FY2021Sep 30, 2021$52.00K-95.8%
Q2 FY2021Jun 30, 2021$61.00K-94.6%
Q4 FY2020Dec 31, 2020$512.00K-80.3%
Q3 FY2020Sep 30, 2020$322.00K-85.3%
Q4 FY2019Dec 31, 2019$1.24M–
Q4 FY2018Dec 31, 2018$1.14M–
Q4 FY2017Dec 31, 2017$2.60M–
Q4 FY2016Dec 31, 2016$2.19M–

More Kamada figures

See a number that looks wrong?